1 – 20 of 20
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
- 2023
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Adjuvant checkpoint inhibition after cystectomy–why, when, and for whom?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Swedish National Guidelines on Urothelial Carcinoma : 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
(
- Contribution to journal › Article
-
Mark
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping : Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
(
- Contribution to journal › Scientific review
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
- 2020
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer : A Swedish nationwide population-based cohort study
(
- Contribution to journal › Article
- 2018
-
Mark
Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Molecular Characterization of Bladder Cancer Subtypes
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy
(
- Contribution to journal › Article
-
Mark
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
(
- Contribution to journal › Article
- 2017
-
Mark
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
(
- Contribution to journal › Article
-
Mark
[18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Epigenetic and Phenotypic Profiling of Urothelial Carcinoma
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
On the Origin of Syn- and Metachronous Urothelial Carcinomas.
(
- Contribution to journal › Scientific review
-
Mark
Urothelial carcinoma in the prostatic urethra and prostate: current controversies
(
- Contribution to journal › Scientific review
- 2006
-
Mark
MOLECULAR PROFILING OF UROTHELIAL CARCINOMA
2006) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)